A one-shot Covid vaccine could be targeted at people who are reluctant to have the jab in areas hit by a surge in cases, it is understood.
The Johnson & Johnson jab works as a single dose, meaning recipients do not need to return for a second injection. The UK has already ordered 30million doses of the Janssen jab, made by Johnson & Johnson, which is awaiting safety approval by British medical regulators is could get approval any day now.
It has been suggested the one-shot jab could be targeted at people who have previously refused offers of the vaccine, particularly in Covid 'hotspots'.
A health source told The Telegraph: “It will be a really useful addition, it could help us to catch up in areas where we have seen vaccine hesitancy,